AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Why Is 111, Inc. Shifting Its ADS StrategyWhy Is 111, Inc. Shifting Its ADS Strategy??
January 08, 2025 09:40 PM AEDT| By Team Kalkine MediaHighlights,111, Inc. has announced a change to its ADS ratio.,The new ratio will shift from 1 ADS representing 2 Class A ordinary shares to 1 ADS representing 20 Class A ordinary shares.,Trading will continue under the Nasdaq ticker symbol 'YI' with...
What’s Behind the Recent Struggles of Apogee Therapeutics' Stock?
January 08, 2025 09:30 PM AEDT| By Team Kalkine MediaHighlights,Apogee Therapeutics operates within the biotechnology sector, focused on medical innovation.,Market capitalization of $2.23 billion with notable fluctuations in its stock price over the past year.,Beta coefficient of 2.26 reflects higher s...
Regent Peak Wealth Adjusts Stake in Johnson & Johnson
January 08, 2025 05:59 AM AEDT| By Team Kalkine MediaHeadlines,Regent Peak Wealth Advisors Adjusts Stake in Johnson & Johnson,Other Institutional Investors Make Strategic Adjustments to Holdings,Johnson & Johnson's Institutional Ownership Remains Strong,Johnson & Johnson (NYSE:JNJ) Ownership Adjustment...
Rising Stake in Mettler-Toledo International (NYSE:MTD) Amid Institutional Demand
January 08, 2025 04:10 AM AEDT| By Team Kalkine MediaHighlights,Pensionfund Sabic increases stake in Mettler-Toledo International by 53.3%.,JPMorgan Chase & Co. and other institutional investors make significant adjustments.,Mettler-Toledo's performance continues to gain investor confidence.,Mettler-To...
How Bristol-Myers Squibb Manages Debt with Strong Earnings (NYSE:BMY)
January 08, 2025 03:51 AM AEDT| By Team Kalkine MediaHighlights,Bristol-Myers Squibb manages its debt effectively with solid earnings.,A substantial cash reserve supports the company's debt obligations.,Debt-to-EBITDA ratio and strong interest coverage signal sound financial management.,Bristol-Myers S...
Select Medical Sees Positive Momentum in Latest Financial Results (NYSE:SEM)
January 08, 2025 03:45 AM AEDT| By Team Kalkine MediaHighlights,Select Medical posted a strong quarterly revenue increase.,The company's net margin stands at 3.97%, reflecting solid profitability.,Institutional investors significantly boosted their stakes in Select Medical.,Select Medical Holdings cont...
How Bristol-Myers Squibb Manages Debt with Strong Earnings (NYSE:BMY)
January 08, 2025 03:44 AM AEDT| By Team Kalkine MediaHighlights,Bristol-Myers Squibb manages its debt effectively with solid earnings.,A substantial cash reserve supports the company's debt obligations.,Debt-to-EBITDA ratio and strong interest coverage signal sound financial management.,Bristol-Myers S...
Cencora, Inc. (NYSE:COR) Shows Resilience with Dividend Increase
January 08, 2025 03:35 AM AEDT| By Team Kalkine MediaHighlights,Nordea Investment Management AB increases stake in Cencora, Inc. by 40.2%.,Cencora boosts dividend payout, signaling positive performance.,Institutional investors hold 97.52% of Cencora’s stock.,Nordea Investment Management AB has signific...
Is Verona Pharma's Debt Position Putting Its Growth at Risk?
January 07, 2025 10:14 PM AEDT| By Team Kalkine MediaHighlights:,Debt acts as a means for companies to access capital, but it introduces risks if not managed effectively.,Mismanagement of debt can lead to shareholder dilution and, in extreme cases, bankruptcy.,It is important to evaluate a company’s de...
Is Cortexyme's Recent Price Movement a Sign of a Bigger Shift in Market Sentiment?
January 07, 2025 09:41 PM AEDT| By Team Kalkine MediaHighlights:,Cortexyme's,(NASDAQ:CRTX),stock surpassed its two hundred day moving average.,The stock reached a high of $1.95 during trading.,A total of 118,865 shares were traded on the day.,Biotechnology is a dynamic sector focused on the development...
Stryker (NYSE: SYK) to Acquire Inari Medical (NASDAQ: NARI) for $4.9 Billion, Strengthening VTE Treatment Portfolio
January 07, 2025 05:33 PM AEDT| By Team Kalkine MediaHighlights,Stryker agrees to acquire Inari Medical for $80 per share, totaling $4.9 billion,Acquisition strengthens Stryker’s position in the venous thromboembolism (VTE) treatment market,Expected to close by the end of Q1 2025, pending regulatory ap...
Viking Therapeutics (NASDAQ: VKTX) to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 07, 2025 05:20 PM AEDT| By Team Kalkine MediaHighlights,Viking Therapeutics CEO Brian Lian to present on January 13, 2025, at the J.P. Morgan Healthcare Conference,The presentation will be available via live webcast for investors and stakeholders,Viking Therapeutics continues to focus on develo...
Is the US healthcare system so flawed that it could drive someone to murder?
January 07, 2025 08:09 AM AEDT| By InvezzKevin Dwyer, a cystic fibrosis patient, had to enlist a team of lawyers and share his story on the Today Show to gain approval for a life-changing medication. Dwyer comes from a family of seven children, four of whom, including himself, suffer from c...
HMPV virus spreads outside China: are we staring at another pandemic?
January 06, 2025 11:58 PM AEDT| By InvezzHealth authorities worldwide are on high alert as human metapneumovirus (HMPV) cases surface beyond China’s borders, raising concerns about the potential for a global outbreak. Though China has yet to release official data on the virus’s...
Could Market Trends Be Signaling Trouble for Xenon Pharmaceuticals?
January 06, 2025 09:42 PM AEDT| By Team Kalkine MediaHighlights,Xenon Pharmaceuticals operates within the biotechnology sector, focusing on treatments for neurological disorders.,Shares of Xenon Pharmaceuticals began trading at a price above their short-term average on Monday.,The company exhibits a st...
N4 Pharma: Navigating Market Challenges with Innovative Drug Delivery Technologies
January 06, 2025 09:41 PM AEDT| By Team Kalkine MediaHeadlines,N4 Pharma experiences significant drop in stock price,The company specializes in novel drug delivery systems for oncology and gene therapy,N4 Pharma’s unique delivery technologies could drive future growth,N4 Pharma Faces Decline Amid Marke...
AEON Biopharma (NYSE: AEON) Announces Proposed Public Offering to Raise Capital for Corporate Needs
January 06, 2025 02:22 PM AEDT| By Team Kalkine MediaHighlights,Plans to raise capital through units comprising common stock and warrants to purchase stock.,Aegis Capital Corp. appointed as book-running manager for the offering.,Net proceeds intended for general corporate and working capital purposes.,...
Bristol-Myers Squibb (NYSE:BMY) Exceeds Expectations, Raises Dividend
January 04, 2025 03:40 AM AEDT| By Team Kalkine MediaHighlights,Bristol-Myers Squibb sees a massive surge in call options.,The company exceeds earnings expectations with strong revenue growth.,Dividend,hike reflects Bristol-Myers Squibb’s ongoing commitment to shareholders.,Bristol-Myers Squibb Company...
Johnson & Johnson (NYSE:JNJ) Sees Modest Increase After Dividend Declaration
January 04, 2025 03:05 AM AEDT| By Team Kalkine MediaHighlights,Johnson & Johnson stock saw a 0.2% rise following a dividend announcement.,Shares traded as high as $145.77, with 1.2 million shares exchanged.,The company reported strong earnings with revenue growth in its recent quarter.,Johnson & Johns...
_01_03_2025_18_49_52_768962.jpg)
Analyzing Capital Allocation at U.S. Physical Therapy (NYSE:USPH)
January 04, 2025 02:48 AM AEDT| By Team Kalkine MediaHighlights,S. Physical Therapy has seen a decline in returns on capital.,Capital allocation trends have not significantly boosted sales.,The stock has fallen by 17% in the past five years, reflecting market doubts.,U.S. Physical Therapy Inc. has been...
